ey0016.3-12 | New Genes | ESPEYB16
A Stoupa , F Adam , D Kariyawasam , C Strassel , S Gawade , G Szinnai , A Kauskot , D Lasne , C Janke , K Natarajan , A Schmitt , C Bole-Feysot , P Nitschke , J Leger , F Jabot-Hanin , F Tores , A Michel , A Munnich , C Besmond , R Scharfmann , F Lanza , D Borgel , M Poalk , A Carre
ey0016.11-8 | Metabolic Signaling | ESPEYB16
C Crewe , N Joffin , JM Rutkowski , M Kim , F Zhang , DA Towler , R Gordillo , PE Scherer
ey0016.15-9 | (1) | ESPEYB16
F Wu , MJ Buscot , M Juonala , N Hutri-Kahonen , JSA Viikari , OT Raitakari , CG Magnussen
ey0016.15-18 | (1) | ESPEYB16
C Ohlsson , DA Hagg , F Hammarhjelm , A Dalmau Gasull , J Bellman , SH Windahl , V Palsdottir , JO Jansson
ey0015.6-11 | Disorders of Sex Development: New paradigm | ESPEYB15
F Zhao , HL Franco , KF Rodriguez , PR Brown , MJ Tsai , SY Tsai , HH Yao
ey0015.7-13 | Secular trends and Turner syndrome | ESPEYB15
J Woelfle , A Lindberg , F Aydin , KK Ong , C Camacho-Hubner , B Gohlke
ey0015.8-4 | New Mechanisms | ESPEYB15
F Spiga , E Zavala , JJ Walker , Z Zhao , JR Terry , SL Lightman
ey0015.9-13 | Biologic agents in chronic inflammatory diseases: lights and shadows | ESPEYB15
L Haas , R Chevalier , BT Major , F Enders , S Kumar , J Tung
ey0015.12-9 | Important for clinical practice | ESPEYB15
AL Heikkinen , F Pakkila , AL Hartikainen , M Vaarasmaki , T Mannisto , E Suvanto
ey0015.13-11 | Type 1 and Type 2 Diabetes in Resource-Limited Settings | ESPEYB15
A Rowlands , E Ameyaw , F Rutagarama , J Dipsesalema , ES Majaliwa , J Mbogo , GD Ogle , JP Chanoine